Exact Sciences
EXAS
#1890
Rank
ยฃ6.12 B
Marketcap
ยฃ32.98
Share price
-3.91%
Change (1 day)
-40.58%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2024 (TTM): -ยฃ0.81 Billion

According to Exact Sciences's latest financial reports the company's current earnings are ยฃ2.75 Billion. a decrease over its 2023 earnings that were of -ยฃ0.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2024

Annual earnings

Year Earnings Change
2024 -ยฃ0.79 Billion435.08%
2023 -ยฃ0.15 Billion-69.28%
2022 -ยฃ0.48 Billion-25.55%
2021 -ยฃ0.65 Billion1.68%
2020 -ยฃ0.64 Billion271.17%
2019 -ยฃ0.18 Billion58.99%
2018 -ยฃ0.11 Billion20.89%
2017 -ยฃ88.67 Million-30.95%
2016 -ยฃ0.13 Billion5.09%
2015 -ยฃ0.13 Billion57.24%
2014 -ยฃ77.71 Million116.53%
2013 -ยฃ35.89 Million
2011 -ยฃ22.35 Million143.73%
2010 -ยฃ9.17 Million27.85%
2009 -ยฃ7.18 Million0.27%
2008 -ยฃ7.16 Million-20.95%
2007 -ยฃ9.05 Million-13.53%
2006 -ยฃ10.47 Million-10.07%
2005 -ยฃ11.64 Million-21.81%
2004 -ยฃ14.88 Million-33.44%
2003 -ยฃ22.36 Million-6.51%
2002 -ยฃ23.92 Million17.95%
2001 -ยฃ20.28 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-ยฃ93.49 Million-88.12%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ51.07 M-106.49%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ19.95 M-102.54%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ27.11 Million-96.56%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ6.15 B-882.10%๐Ÿ‡ซ๐Ÿ‡ท France